Improved outcomes in NOD mice treated with a novel Th2 cytokine-biasing NKT cell activator.
收藏ImmuneData2026-05-28 收录
数据链接：
官方服务：
资源简介：
Injection of the glycolipid alpha-GalCer (20:2) reduced the percentage of iNKT cells, stained with CD1d/epitope tetramers, at 1 to 30 wk post-injection in the spleen and and at 5-30 wk in peripheral lymph node cells.
提供机构：
IEDB创建时间：
2007-01-01
